T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$1.7B |
| 2 |
Verizon
VZ
|
+$1.36B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 4 |
US Bancorp
USB
|
+$1.29B |
| 5 |
Merck
MRK
|
+$1.23B |
Top Sells
| 1 |
Amazon
AMZN
|
+$5.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$4.57B |
| 3 |
Tesla
TSLA
|
+$3.67B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.43B |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.69% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Ovintiv
OVV
$10.9B
| $9.98M | ﹤0.01% |
196,717
-13,675
| -6% | -$693K |
|
|
EVA
1052
DELISTED
Enviva Inc.
EVA
| $9.84M | ﹤0.01% |
185,830
-121,457
| -40% | -$6.43M |
|
1053
Vir Biotechnology
VIR
$727M
| $9.76M | ﹤0.01% |
385,648
+39
| +0% | +$987 |
|
1054
Markel Group
MKL
$24.8B
| $9.75M | ﹤0.01% |
7,401
+812
| +12% | +$1.07M |
|
1055
Brookfield Asset Management
BAM
$91.5B
| $9.71M | ﹤0.01% |
+338,719
| New | +$9.71M |
|
1056
Petrobras
PBR
$81.6B
| $9.7M | ﹤0.01% |
910,677
-311,006
| -25% | -$3.31M |
|
1057
CI&T Inc
CINT
$686M
| $9.57M | ﹤0.01% |
1,471,732
+108,890
| +8% | +$708K |
|
1058
Organon & Co
OGN
$2.77B
| $9.5M | ﹤0.01% |
340,241
+3,036
| +0.9% | +$84.8K |
|
1059
Thryv Holdings
THRY
$571M
| $9.5M | ﹤0.01% |
500,164
+388
| +0.1% | +$7.37K |
|
1060
Pentair
PNR
$18.5B
| $9.33M | ﹤0.01% |
207,502
+348
| +0.2% | +$15.7K |
|
1061
DraftKings
DKNG
$22.8B
| $9.33M | ﹤0.01% |
819,310
+30,666
| +4% | +$349K |
|
1062
iShares Core S&P 500 ETF
IVV
$675B
| $9.27M | ﹤0.01% |
24,130
+18
| +0.1% | +$6.92K |
|
1063
Carlisle Companies
CSL
$16.8B
| $9.03M | ﹤0.01% |
38,297
+6,939
| +22% | +$1.64M |
|
1064
Badger Meter
BMI
$5.34B
| $9.01M | ﹤0.01% |
82,647
+6,285
| +8% | +$685K |
|
1065
Tenaya Therapeutics
TNYA
$209M
| $8.99M | ﹤0.01% |
4,472,202
+2,357,950
| +112% | +$4.74M |
|
1066
Belden
BDC
$5.29B
| $8.94M | ﹤0.01% |
124,408
-23,346
| -16% | -$1.68M |
|
1067
RH
RH
$4.27B
| $8.92M | ﹤0.01% |
33,391
+92
| +0.3% | +$24.6K |
|
|
UNVR
1068
DELISTED
Univar Solutions Inc.
UNVR
| $8.92M | ﹤0.01% |
280,407
+1,883
| +0.7% | +$59.9K |
|
|
1069
Berkshire Hathaway Class A
BRK.A
$1.07T
| $8.91M | ﹤0.01% |
19
| – | – |
|
1070
RXO
RXO
$2.81B
| $8.78M | ﹤0.01% |
+510,141
| New | +$8.78M |
|
1071
Skechers
SKX
$9.49B
| $8.77M | ﹤0.01% |
209,013
+5,609
| +3% | +$235K |
|
1072
iShares Core US Aggregate Bond ETF
AGG
$132B
| $8.67M | ﹤0.01% |
89,375
-1,629
| -2% | -$158K |
|
1073
National Bank Holdings
NBHC
$1.47B
| $8.66M | ﹤0.01% |
205,856
+16,957
| +9% | +$713K |
|
1074
MoonLake Immunotherapeutics
MLTX
$3.45B
| $8.64M | ﹤0.01% |
822,601
-46,787
| -5% | -$491K |
|
1075
ServisFirst Bancshares
SFBS
$4.63B
| $8.63M | ﹤0.01% |
125,175
+101,122
| +420% | +$6.97M |
|